[
  {
    "id": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1--chunk-0",
    "bookId": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1-",
    "sectionTitle": "Impulse Oscillometry",
    "content": "<!-- Page 1 -->\n\n\n\n# Impulse Oscillometry\nDr Karthik N\nMD, DNB, IDCCM, Fellowship in Allergy & Clinical Immunology (EAACI)\n\n---\n\n<!-- Page 2 -->\n\n\n\n# Specific Learning Objectives\n\n*   Technology\n*   Measurements\n*   Significance\n*   IOS vs FOT\n*   Oscillometry vs PFT\n*   Interpretation\n\n---\n\n<!-- Page 3 -->\n\n\n\n# Introduction\n\n\n\n## Lung Function\n\n*   **Ventilation**\n    *   **Airways**\n        *   **Airflow**\n            *   PFT\n            *   Impulse Oscillometry\n            *   Peak Flow meter\n        *   **Inflammation**\n            *   Sputum Eosinophils\n            *   FeNO\n    *   **Lung volumes**\n        *   Body Plethysmography\n        *   Helium Dilution\n    *   **Lung mechanics**\n        *   MIP\n        *   MEP\n*   **Gas Exchange**\n    *   **Diffusion**\n        *   DLCO\n        *   6MWT\n\n---\n\n<!-- Page 4 -->\n\n\n\n# Airway Anatomy\n\n*   23 generations of airways\n*   Dichotomous branching\n*   1-15: Conducting airways\n*   16-23: Respiratory airways\n*   Small airways: size < 2mm *internal diameter*\n\n**Diagrammatic Representation of Airway Generations and Corresponding Data**\n\nThe diagram illustrates the branching of airways from the trachea down to alveolar sacs, categorized into a \"Conducting zone\" and a \"Transitional and respiratory zones\".\n\n*   **Conducting zone:** Trachea, Bronchi, Bronchioles, Terminal bronchioles\n*   **Transitional and respiratory zones:** Respiratory bronchioles, Alveolar ducts (T₃, T₂, T₁), Alveolar sacs (T)\n\nA handwritten note indicates \"start of smallest airways < 2mm\" pointing to Generation 5.\n\n| Generation | Diameter, cm | Length, cm | Number | Total cross sectional area, cm² |\n| :--------- | :----------- | :--------- | :----- | :------------------------------ |\n| 0          | 1.80         | 12.0       | 1      | 2.54                            |\n| 1          | 1.22         | 4.8        | 2      | 2.33                            |\n| 2          | 0.83         | 1.9        | 4      | 2.13                            |\n| 3          | 0.56         | 0.8        | 8      | 2.00                            |\n| 4          | 0.45         | 1.3        | 16     | 2.48                            |\n| 5          | 0.35         | 1.07       | 32     | 3.11                            |\n| ↓          | ↓            | ↓          | ↓      | ↓                               |\n| 16         | 0.06         | 0.17       | 6x10⁴  | 180.0                           |\n| 17         | ↓            | ↓          | ↓      | ↓                               |\n| 18         |              |            |        |                                 |\n| 19         | 0.05         | 0.10       | 5x10⁵  | 10³                             |\n| T₃ 20      |              |            |        |                                 |\n| T₂ 21      |              |            |        |                                 |\n| T₁ 22      |              |            |        |                                 |\n| T 23       | 0.04         | 0.05       | 8x10⁶  | 10⁴                             |\n\nV. Ranga. J. Kleinerman. Structure and function of small airways in health and disease.\n\n---\n\n<!-- Page 5 -->\n\n\n\n# Small Airways vs Large Airways\n\n| Feature                 | Large Airways                       | Small Airways             |\n| :---------------------- | :---------------------------------- | :------------------------ |\n| Generation              | Up to 8th generation                | 8th and beyond            |\n| Cross Sectional Area    | Small                               | Large                     |\n| Cartilage               | Present                             | Absent                    |\n| Surfactant Lining       | Absent                              | Present                   |\n| Airflow                 | Turbulent Convection                | Laminar Diffusion         |\n| Resistance              | 75-90%                              | 10-25%                    |\n| Collateral ventilation  | Absent                              | Present                   |\n| Effect of lung volume   | Reduces with reduced lung volume    | Unaffected by lung volume |\n\n---\n\n<!-- Page 6 -->\n\n\n\n# Spirometry\n\n*   Most widely used lung function test\n*   <u>Most airway resistance occurs between 4th – 8th generation airways</u>\n*   FEV1 commonly large airway obstruction\n    *   Dependent on lung volumes\n    *   Elasticity\n    *   Patient effort\n\n**Diagram Labels:**\n*   PEF, MEF\n*   FEF 25%\n*   FEF 50%\n*   FEF 75%\n*   FVC\n*   Volume (L)\n*   Expiration\n*   Inspiration\n*   Flow (liters per second)\n*   FIF 25%\n*   FIF 50%\n*   FIF 75%\n\n---\n\n<!-- Page 7 -->\n\n\n\n# Role of Sound waves in lung function\n\n*   Arthur DuBois (1956)\n    *   ✓ **Forced Oscillation Technique (FOT)**\n    *   ✓ Single frequency sound waves to tidal breathing\n*   Modified Ohm's Law\n    Airflow = $\\frac{\\Delta \\text{pressure}}{\\text{Resistance}}$ $\\rightarrow$ Resistance = $\\frac{\\Delta P}{\\text{Flow}}$\n    *   *Handwritten notes:*\n        *   pressure difference at both ends of tube\n        *   Flow (sound) of air in tube\n*   ✓ Impedence (Zrs) is the pressure to be overcome to maintain forward airflow\n    *   Considers the properties of conducting pathways and alveoli\n\n*Graph Labels:*\n*   Patient's Quiet Breathing\n*   Tremolo Oscillation\n*   Measured Waveform\n\n---\n\n<!-- Page 8 -->\n\n\n\n# Impedence of Respiratory system\n*The pressure required to overcome the resistance inside tube/Airways.*\n\n\n\n## Components of Respiratory System Impedance\n\n*   **Resistance (Rrs)**\n    *   Influenced by: Airway calibre, Airflow determined\n\n*   **Reactance (Xrs)**\n    *   Composed of:\n        *   **Inertance**\n            *   Derived from: Volume of gas\n            *   *Annotation:* ? Obvious/Inertia Provides Inertia for new air Entry\n        *   **Elastance / capacitance**\n            *   Derived from: Elastic properties, Small airways, alveoli\n            *   *Annotation:* Ability to Expand & absorb the pressure\n\n\n\n## Total Respiratory System Impedance\n\n$Zrs = Rrs + Xrs$\n\n---\n\n<!-- Page 9 -->\n\n\n\n# Role of Sound Frequency (Hz)\n\n*   Distance travelled by sound is determined by frequency\n    *   Higher frequencies -> shorter distances\n    *   Lower Frequencies -> longer distances\n\nR5: Resistance @ 5Hz (Entire Lung)\nR20: Resistance @ 20Hz (Large Airways)\nR5-R20: Peripheral airway resistance\n\nX5: Reactance @5Hz (Entire lung Elastance)\nX20: Reactance @20Hz (inertance)\n\n| Curvilinear | Linear    |\n| :---------- | :-------- |\n| 2-5MHz      | 5-10MHz   |\n| 30cm        | 9cm       |\n\nUsed for DVT diagnosis\n\nGallbladder, kidney, liver, bladder, uterus, ovaries, aorta\nArteries, veins, skin, musculoskeletal, testicles, eyes, breast\n\nMouth, cheeks, throat\nR20\nR5\nAlveoli\n\n---\n\n<!-- Page 10 -->\n\n\n\n# Parts of Forced Oscillometry Device\n\n\n\n## Diagram Labels:\n\n*   ① Airflow\n*   ② Loud speaker impulses\n*   Impulse:flow\n*   Respiratory:flow\n*   Mouthpiece\n*   ③ Flow transducer\n*   ③ Pressure transducer\n\n\n\n## Graph Labels:\n\n*   Amplitude (Y-axis)\n*   Time (X-axis)\n\n\n\n## Handwritten Notes:\n\n*   (Next to Flow transducer and Pressure transducer) pressure change & flow sensed\n\n---\n\n<!-- Page 11 -->\n\n\n\n# Impulse Oscillometry\n\n*   Michaelson in 1976\n    *   **Square wave pattern** of sound oscillation\n        *   Multiple frequencies simultaneously (Handwritten note: \"Advantage\" pointing to this line)\n    *   Impulse Oscillometry System (IOS)\n*   Frequencies from **3Hz – 30Hz at a time**\n\n---\n\n**Diagrams:**\n\n*   **Sinusoidal wave oscillation of FOT**\n    (A sine wave is depicted)\n*   **Square wave oscillation of IOS**\n    (A square wave is depicted)\n\n---\n\n**Images:**\n\n*   A computer setup displaying data, connected to a medical device, likely the Impulse Oscillometry System.\n*   A patient undergoing an Impulse Oscillometry test, with a device held to their mouth and nose.\n\n---\n\n<!-- Page 12 -->\n\n\n\n# IOS vs FOT\n\n| FOT                               | IOS                                     |\n| :-------------------------------- | :-------------------------------------- |\n| Tidal Breathing                   | Tidal Breathing                         |\n| Sinusoidal wave oscillation       | Square Wave Oscillation                 |\n| Single Frequency at a time        | Multiple Frequencies in same sitting    |\n| Multiple measurements             | Few measurements                        |\n| Better Temporal resolution        | Poor Temporal Resolution                |\n| Cumbersome, large                 | Easy to perform, portable               |\n| Poor Signal Noise Characteristics | Better Signal Noise Characteristics     |\n\nAs present since long time\nDis Adv:-\n\nAirway Oscillometry\nOr\nLung Oscillation\nTechnique\n\n---\n\n<!-- Page 13 -->\n\n\n\n# How to Perform\n\n*   Comfortable seated position, nose clips\n*   Neck neutral\n*   Cheek support [cheek can absorb some pressure]\n*   Mouth piece – firm seal\n*   Tidal breathing for 30s\n*   Minimum 3 readings I.O.T.\n*   Coherence >0.9 (near +0.1 is good)\n    *   quality of result\n\n*(Text from image labels)*\n*   Cheek support\n*   Neck in neutral position\n\n---\n\n<!-- Page 14 -->\n\n\n\n# Oscillogram\n\n![Graph showing Resistance and Reactance vs. Frequency](image_placeholder)\n\n**Legend:**\n--- Resistance\n- - - Reactance\n\n**Y-axis:** Resistance or Reactance (cmH2O/L/s)\n**X-axis:** Frequency (Hz)\n\n**Points on graph:**\n*   R5\n*   R20\n*   X20\n*   Fres (Resonant Frequency)\n*   AX (Shaded area)\n\n**Handwritten Note:**\nX5 is usually a -ve value, because the pressure is Absorbed therefore Lost in the Alveoli. so 5Hz [X5] reaches upto level of Alveoli\n\n**Definitions:**\n*   **Fres:** Resonant Frequency (point at which elastance = inertance)\n*   **AX:** Area of Reactance\n    *   Area under Fres and b/w X5\n    *   Determinant of tissue elastance\n\nGoldman Triangle\n\n---\n\n<!-- Page 15 -->",
    "wordCount": 1304,
    "index": 0,
    "subTopicId": "1766794361794-d9nf9h13q"
  },
  {
    "id": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1--chunk-1",
    "bookId": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1-",
    "sectionTitle": "Measurements",
    "content": "# Measurements\n\n*   R5: Resistance at 5Hz (Entire Lung)\n*   R20: Resistance at 20 Hz (Large airway)\n*   R5-R20: Peripheral airway resistance\n\n*   X5: Reactance at 5Hz (Elastic property of lung, small airway)\n*   AX: Area of reactance (Elastic property of lung, small airway)\n*   X20: Reactance at 20Hz (Inertance of air column)\n\n*   Fres: Resonant Frequency (Elastance = Inertance)\n\n---\n\n<!-- Page 16 -->\n\n\n\n# Original Article\n\n\n\n## Small Airway Dysfunction by Impulse Oscillometry in Symptomatic Patients with Preserved Pulmonary Function\n\n\n\n### TABLE III. Cutoff values of SAD-related IOS parameters in patients with PPF (N = 255)\n\n| IOS parameter | Cutoff value | Sensitivity (%) | Specificity (%) | LR (+) | LR (-) | AUC | Youden index | P value |\n| :------------ | :----------- | :-------------- | :-------------- | :----- | :----- | :-- | :----------- | :------ |\n| $R_5 - R_{20}$ | $>0.07$      | $62.5$          | $59.7$          | $1.55$ | $0.63$ | $0.62$ | $0.22$       | $<.01$  |\n| $X_5$         | $<-0.12$     | $46.9$          | $77.5$          | $2.08$ | $0.69$ | $0.64$ | $0.24$       | $<.01$  |\n| $F_{res}$     | $>14.14$     | $75.0$          | $57.9$          | $1.78$ | $0.43$ | $0.69$ | $0.33$       | $<.01$  |\n| $AX$          | $>0.44$      | $65.6$          | $61.9$          | $1.72$ | $0.56$ | $0.67$ | $0.28$       | $<.01$  |\n\n\n\n### TABLE V. Incidence of SAD defined by $FEF_{25\\%-75\\%}$ and IOS parameters\n\n| Small airway parameter                      | Nonobstructive group ($FEV_1/FVC \\ge 0.7$) BR (-) (N = 255) | Nonobstructive group ($FEV_1/FVC \\ge 0.7$) BR (+) (N = 16) | Obstructive group ($FEV_1/FVC < 0.7$) BR (-) (N = 62) | Obstructive group ($FEV_1/FVC < 0.7$) BR (+) (N = 16) |\n| :------------------------------------------ | :---------------------------------------------------------- | :---------------------------------------------------------- | :----------------------------------------------------- | :----------------------------------------------------- |\n| $FEF_{25\\%-75\\%} < 65\\%$ predicted, n (%) | $64 (25.1)$                                                 | $10 (62.5)$                                                 | $62 (100)$                                             | $16 (100)$                                             |\n| $R_5 - R_{20} > 0.07$, n (%)                | $127 (49.8)$                                                | $7 (43.8)$                                                  | $50 (80.6)$                                            | $14 (87.5)$                                            |\n| $X_5 < -0.12$, n (%)                        | $74 (29.0)$                                                 | $7 (43.8)$                                                  | $39 (62.9)$                                            | $14 (87.5)$                                            |\n| $F_{res} > 14.14$ Hz, n (%)                 | $128 (50.2)$                                                | $11 (68.8)$                                                 | $54 (87.1)$                                            | $15 (93.8)$                                            |\n| $AX > 0.44$, n (%)                          | $111 (43.5)$                                                | $10 (62.5)$                                                 | $51 (82.3)$                                            | $15 (93.8)$                                            |\n\n---\n\n<!-- Page 17 -->\n\n\n\n# Oscillogram\n\n\n\n## Axis Labels\n\n*   **Y-axis**: Resistance or Reactance (cmH2O/L/s)\n*   **X-axis**: Frequency (Hz)\n\n\n\n## Legend\n\n*   **Resistance**: (represented by a solid line)\n*   **Reactance**: (represented by a dashed-dotted line)\n\n\n\n## Graph Labels\n\n*   R$_5$\n*   R$_{20}$\n*   X$_5$\n*   X$_{20}$\n*   F$_{res}$\n*   AX\n\n\n\n## Y-axis Scale\n\n*   1.5\n*   1.0\n*   0.5\n*   -0.5\n*   -1.0\n\n\n\n## Annotation\n\n*   (n) (circled symbol)\n\n---\n\n<!-- Page 18 -->\n\n\n\n# Oscillogram – Large Airway Obstruction\n\nResistance or Reactance (cmH2O/L/s)\n\nFrequency (Hz)\n\n---\n\n**Legend:**\n*   --- Resistance\n*   -.-.- Reactance\n\n---\n\n**Graph Labels:**\n*   R₅\n*   R₂₀\n*   X₅\n*   X₂₀\n*   F_res\n*   AX\n\n---\n\n<!-- Page 19 -->\n\nOscillogram\n\nResistance or Reactance (cmH2O/L/s)\nFrequency (Hz)\n\n**Legend**\n--- Resistance\n- - - Reactance\n\n**Graph Labels**\nR$_{5}$\nR$_{20}$\nX$_{5}$\nX$_{20}$\nF$_{res}$\nAX\n\n---\n\n<!-- Page 20 -->\n\n\n\n# Oscillogram – Small Airway Obstruction\n\n\n\n## Graph Description\n\n**Y-axis:** Resistance or Reactance (cmH2O/L/s)\n**X-axis:** Frequency (Hz)\n\n**Legend:**\n*   --- Resistance\n*   - . - . - Reactance\n\n**Key points on graph:**\n*   **Resistance curve (solid line):** Shows higher resistance at lower frequencies (labeled R5) and decreases as frequency increases (labeled R20). An upward arrow indicates an increase at R5.\n*   **Reactance curve (dashed-dotted line):** Starts at a negative value at low frequencies (labeled X5), increases towards zero, crosses the x-axis at F_res (Resonant Frequency), and then becomes positive at higher frequencies (labeled X20). A downward arrow indicates a decrease at X5.\n*   **Shaded area:** Labeled AX, representing the area under the reactance curve at low frequencies.\n\n\n\n## Handwritten Annotations\n\n*   **R5:** R5 → Pred for entire lung\n*   **R20:** R20 → less Pred\n*   **X5/AX explanation:** Because smaller Airways have more obstructed. More air gets trapped in them. + tissue becomes less Elastic → so more -ve X5 seen → AX ↑res\n\n---\n\n<!-- Page 21 -->\n\nOscillogram\n\nResistance or Reactance (cmH20/L/s)\n1.5\n1.0\n0.5\n0\n-0.5\n-1.0\n\nR₅\nR₂₀\n\nX₅\nX₂₀\n\nAX\nF_res\n\nFrequency (Hz)\n\nResistance\nReactance\n\n---\n\n<!-- Page 22 -->\n\n\n\n# Oscillogram - ILD\n\n\n\n## Graph\n\n**Y-axis:** Resistance or Reactance (cmH2O/L/s)\n**X-axis:** Frequency (Hz)\n\n**Legend:**\n*   --- Resistance\n*   - - - Reactance\n\n**Graph Annotations:**\n*   R5\n*   R20 (not much change in R5 - R20)\n*   X20\n*   AX (shaded area)\n*   X5 → more -ve [as they loose their Elastic property] Absorb More pressure\n*   F_res ↑ses & shifts more to right.\n\n---\n\n<!-- Page 23 -->\n\n\n\n# Interpretation\n\n| Diseases                                    | R5                | R20 | X5                                             | Fres                                           |\n| :------------------------------------------ | :---------------- | :-- | :--------------------------------------------- | :--------------------------------------------- |\n| Proximal Airway Obstruction                 | ↑ (Entire lung)   | ↑   | N (As smaller airways not affected)            | N                                              |\n| Peripheral Airway Obstruction (Small airways) | ↑                 | N   | ↑ (Because of air trapping/loss of elasticity) | ↑                                              |\n| Lung Restriction                            | N                 | N   | ↑                                              | ↑                                              |\n\n*   Bronchodilator Response: 40% decrease in R5; 50% increase in X5; 80% decrease in AX (R5 X5 AX 40-50-80)\n*   Bronchoconstrictor Response: 20 – 50% increase in R5 + 20-80% decrease in X5\n\nEur Respir Rev 2022; 31: 210208\n\n---\n\n<!-- Page 24 -->\n\n\n\n# Example\n\n*   40 year old male, known bronchial asthma since 25 years. On MDI ICS+LABA Twice daily. H/o Frequent exacerbations and persistent symptoms, exercise limitation, requiring rescue medications off and on. Lungs hyperinflated on examination. Inhaler adherence & technique good. Trigger avoidance\n*   PFT FEV1/FVC 79%, FEV1: 70%\n\n(Graph showing Resistance (R) and Reactance (X) vs. Frequency, Hz)\n**Y-axis:** R/X, kPa/L/s\n**X-axis:** Frequency, Hz\n\n**Resistance (R)**\n*   Pre-BD (darker curve)\n*   Post-BD (lighter curve)\n\n**Reactance (X)**\n*   Pre-BD (darker curve)\n*   Post-BD (lighter curve)\n\n(Handwritten annotations on graph: \"ar\", \"rso\")\n\nAsthma with SAD\n(Handwritten annotation below box: small airway ds)\n\n---\n\n<!-- Page 25 -->\n\nExample\n\n*   50 year old male, treated PTB 15 years ago. Farmer, reformed smoker.\n*   DOE, wheeze since 12 years. Frequent nebulizer use\n*   PFT: FEV1/FVC 76%, FEV1: 60%, FVC 65%.\n\n(Image of a chest X-ray)\n\n(Graph with two sets of lines, labeled \"Resistance\" and \"Reactance\")\nLabels on graph:\nULN\nLLN\nPre BD\nPost BD\nFrequency [Hz]\n\n(Handwritten text on graph): NO BD response\n\nCOPD\n\n---\n\n<!-- Page 26 -->\n\n\n\n# IOS vs PFT\n\n| | PFT | IOS |\n|---|---|---|\n| **Principle** | Flow sensor/volume displacement<br>Flow rates; lung volumes | Single or multiple frequencies pushed into lungs as pressure waves<br>Respiratory resistance and reactance |\n| **Patient effort** | +++<br>Forced exhalation | +<br>Tidal Breathing |\n| Variability | 3-5% | 5-15% |\n| **Sensitivity to airway location** | Central: +<br>Peripheral: ++ | Central: +++<br>Peripheral: +++ |\n| **Bronchodilator response** | 12-15% FEV1 | 40% decrease in R5 or 50% increase in X5 |\n| Bronchoconstrictor response | 20% FEV1 | 50% for R5 |\n| Standardisation | +++ | ++ |\n| Reference values | +++ | + |\n\n---\n\n<!-- Page 27 -->\n\n\n\n# Uses of Oscillometry\n\n*   Obstructive Airway Diseases\n    *   Asthma\n    *   COPD\n    *   Small Airway Obstruction – Bronchiolitis, SAD Asthma\n*   Bronchial challenge testing\n*   ILDs\n    *   HP\n    *   Fibrotic ILDs\n*   Post Lung Transplant\n    *   CLAD - BOS\n        *   *chronic lung allograft dysfunction – Bronchiolitis obliterans Syndrome*\n\n---\n\n<!-- Page 28 -->\n\n\n\n# Review\n\n*   Oscillometry – tool for assessment of airway and lung elastance\n*   Effort independent\n*   $Zrs = Rrs + Xrs$ (Handwritten: Resistance + Reactance [impedance + elastance] capacitance)\n*   Airway resistance is frequency dependent\n    *   ✓ R5 – Resistance of entire lung ✓\n    *   ✓ R20 – Resistance of large airways ✓\n    *   ✓ X5 – Reactance of entire lung (elasticity dominant) ✓\n    *   AX, Fres – other indicators of small airways/elasticity\n*   ~~Bronchodilator reversibility: 40% in R5, 50% X5, 80% in AX~~ (Handwritten below: R5 X5 AX)\n\n---\n\n<!-- Page 29 -->\n\nThank you\n\n---\n\n<!-- Page 30 -->",
    "wordCount": 1364,
    "index": 1,
    "subTopicId": "1766794361794-d9nf9h13q"
  },
  {
    "id": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1--chunk-2",
    "bookId": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1-",
    "sectionTitle": "FENO Fractional exhaled nitric oxide",
    "content": "# FENO Fractional exhaled nitric oxide\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n1\n\n---\n\n<!-- Page 31 -->\n\n\n\n# INDICATIONS\n\n*   Assessment of cough, wheezing, and dyspnea\n*   Identifying eosinophilic asthma phenotype *\n*   Assessing the potential response to anti-inflammatory agents*, notably inhaled corticosteroids (ICS)*\n    *Rx response*\n*   To guide changes in anti-inflammatory medications in a step-wise manner*\n    *↑ne ↓dse dose*\n    *step up / step down*\n*   To assess whether airway inflammation is contributing to poor asthma control, particularly in the presence of other contributors (eg, rhinosinusitis, anxiety, gastroesophageal reflux, obesity, continued allergen exposure)\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 32 -->\n\n\n\n# NO PRODUCTION\n\n*   In the respiratory tract, *NO* is produced by a wide variety of cell types and is generated through conversion of $\\underline{\\text{L-arginine}}$ to $\\underline{\\text{L-citrulline}}$ by the action of $\\underline{\\text{nitric oxide synthase (NOS)}}$.\n*   *NO* production is induced in the bronchial epithelium by $\\underline{\\text{interferon gamma (IFN}\\gamma\\text{)}}$ via $\\underline{\\text{Janus kinases (JAK)/STAT-1}}$ signaling.\n\n---\n\n**Diagram Text:**\n\n*   L-Arginine\n*   O$_2$\n*   NADPH, Heme, THB4\n*   NOS\n*   Citulline\n*   Nitric oxide (No)\n\n**NOS Types:**\n\n*   NOS1/nNOS (Neural)\n*   NOS2/iNOS (Inducible)\n*   NOS3/eNOS (Endothelial)\n\n---\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 33 -->\n\n\n\n# ROLE OF NO\n\n\n\n## Physiology (Low Concentration: [fM-pM])\n\n*   Regulates the tone of the airway\n*   Regulates pulmonary blood flow\n*   Bronchodilator\n*   Surfactant production\n*   Regulates the permeability of the alveolar capillary membrane\n*   Stimulates the ciliary beat\n*   Anti-inflammatory effect\n*   Mediator in local immunity processes\n*   Neurotransmission (iNANC)\n\n\n\n## Pathophysiology (High Concentration: [nM], ++++ iNOS)\n\n*   Bronchial hyperreactivity\n*   Mucus hypersecretion\n*   Vascular permeability\n*   Vasodilation\n*   Proinflammatory effect\n*   Inhibition of ciliary motility\n*   Production of free radicals\n*   Cytotoxicity\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 34 -->\n\n\n\n# Mechanisms of FeNO Elevation in Type 2 Inflammation\n\n(49:40)\nTH2 → IL4, IL5, IL13\nILC2 → IL5, IL13\n\n\n\n## TYPE 2 INFLAMMATION\n\n*   **IL-5**\n    *   Activation of immune cells\n    *   JAK-2, STAT-3\n    *   IL-5R\n    *   Eosinophil\n    *   Differentiation, activation and survival of eosinophils\n\n*   **IL-4**, **IL-13**\n    *   JAK-1, JAK-3, STAT-6\n    *   IgE production\n    *   Smooth muscle hypertrophy\n    *   iNOS\n    *   Elevated NO production by bronchial epithelial cells\n    *   FeNO\n\n*(Handwritten notes on the right side of the diagram)*\n(5) ↓\n(4, 13) ↓\nJAK-STAT ↓\nIL3 ↓\nIgE ↓\nAines\n\n---\n\n<!-- Page 35 -->\n\n\n\n# METHOD\n\n*   Expirate is continuously sampled by the NO analyzer\n*   patient should be seated comfortably\n*   mouthpiece at the proper height and position\n*   Nose clip should not be used (Curved in imp.OT)\n*   Insert a mouthpiece and inhale over 2 to 3 seconds through the mouth to TLC, or near TLC then exhale immediately, because breath-hold results in NO accumulation\n*   The instrument display and audio signals guide the user to the correct exhalation pressure.\n\nDR. BHARATH KATHI MD DNB FIP (unclear text)\n\n---\n\n<!-- Page 36 -->\n\nTo ensure accuracy and repeatability of results, the FeNO detection process in the adult 10-second mode of the NIOX VERO® requires patients to maintain an exhalation flow rate of 0.05L/s (+/- 10%) for 10 seconds.\n* Children who are not able to perform the 10 second test, the 6 second test is an alternative\nL/min/second\n\nDR. BHARATH KATHI MD DNB FIP FACI EOARM\n\n---\n\n<!-- Page 37 -->\n\n\n\n# Patient Factors Influencing Exhaled NO Value\n\n*   **Age**: In adults, there is no relationship between exhaled NO level and age, but it has been reported that, in children, Feno increases with age.\n*   **Respiratory maneuvers**: Because spirometric maneuvers have been shown to transiently reduce exhaled NO levels it is recommended that NO analysis be performed before spirometry.\n*   **Airway caliber**: Feno level may vary with bronchial obstruction and after bronchodilators.\n*   **Food, medication and beverages.**: Patients should refrain from eating and drinking before NO analysis.\n    An increase in feno has been noticed after intake of nitrates and nitrate containing foods such as lettuce, radish etc, drinking water and ingestion of caffeine may lead to transiently altered Feno.\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 38 -->\n\n*   Alcohol ingestion reduces Feno in patients with asthma and healthy subjects ✓\n*   Exhaled NO falls after treatment with inhaled or oral corticosteroids and after inhaled NO synthase inhibitors ✓\n*   Smoking\n    *   Chronically reduced level of feno have been demonstrated in cigarette smokers. ✓\n*   Subjects should not smoke in the hour before measurements ✓\n*   Infection: Upper and lower respiratory tract viral infections may lead to increased levels of exhaled NO in asthma ✓\n*   HIV infection is associated with reduction in exhaled NO ✓\n*   Hypoxia: decreases exhaled NO. ✓\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 39 -->\n\n\n\n# INTERPRETATION\n\nThe normal level of FeNO is 20 to 30 parts per billion.\n\nWhat Are the Clinically Significant Cut Points for FENO?\n\n**Adults**\n*   Low FENO: < 25 ppb\n*   Intermediate FENO: 25 - 50 ppb\n*   High FENO: > 50 ppb\n\n**Children**\n*   Low FENO: < 20 ppb\n*   Intermediate FENO: 20 - 35 ppb\n*   High FENO: > 35 ppb\n\nDR. BHARATH KATHI MD DNS FIP FAGI SCARM\n\n---\n\n<!-- Page 40 -->\n\nTABLE 5. GENERAL OUTLINE FOR FeNO INTERPRETATION: SYMPTOMS REFER TO COUGH AND/OR WHEEZE AND/OR SHORTNESS OF BREATH\\*\n\n| | FeNO < 25 PPB (<20 ppb in children) | FeNO 25-50 ppb (20-35 ppb in children) | FeNO > 50 ppb (>35 ppb in children) (circled ATS) |\n|---|---|---|---|\n| Symptoms present during past 6+ wk (circled 1) | ✗ Eosinophilic airway inflammation unlikely ✓<br/>Alternative diagnoses ✓<br/>Unlikely to benefit from ICS ✗<br/>(circled 2) Monitoring | Diagnosis<br/>- Be cautious ??<br/>- Evaluate clinical context<br/>✓ Monitor change in FeNO over time | Eosinophilic airway inflammation present ✓<br/>Likely to benefit from ICS ✓ |\n| Symptoms present | Possible alternative diagnoses *<br/>Unlikely to benefit from increase in ICS ✓ | ? Persistent allergen exposure<br/>Inadequate ICS dose ✓<br/>* Poor adherence * ✓<br/>Steroid resistance ?? ✓ | Persistent allergen exposure ✓<br/>Poor adherence or inhaler technique ✓<br/>Inadequate ICS dose ✓<br/>* Risk for exacerbation * ✓<br/>?? |\n| Symptoms absent ✓ | (smiley face)<br/>Adequate ICS dose ✓<br/>Good adherence ✓<br/>ICS taper ✓ | Adequate ICS dosing ✓<br/>Good adherence ✓<br/>✓ Monitor change in FeNO | (circled X)<br/>ICS withdrawal or dose reduction may result in relapse (circled X)<br/>(handwritten: may require continuous of or add biologics)<br/>(handwritten: high dose ICS) |\n\n---\n\n<!-- Page 41 -->\n\n\n\n# PRACTICE POINTS\n\n| LOW                                     | INTERMEDIATE                                       | HIGH                                      |\n| :-------------------------------------- | :------------------------------------------------- | :---------------------------------------- |\n| **Eosinophilic inflammation**           |                                                    |                                           |\n| Less likely                             |                                                    | Likely                                    |\n| <25 ppb (Children <20 ppb)              | 25-50 ppb (Children 20-35 ppb)                     | >50 ppb (Children >35 ppb)                |\n| responsiveness to corticosteroids are less likely | should be interpreted cautiously and with reference to the clinical context | responsiveness to corticosteroids are likely in symptomatic patients |\n\n**Notes:**\n*   Account for age as a factor affecting FeNO in children younger than 12 years of age\n*   Account for persistent and/or high allergen exposure as a factor associated with higher levels of FeNO\n\n*   In a symptomatic patient (chronic cough and/or wheeze and/or shortness of breath during past . 6 wk) presenting for the first time, possible etiologies:\n    *   Atopic asthma, Eosinophilic bronchitis, COPD with mixed inflammatory phenotype\n*   That the patient is likely to benefit from a trial of ICS treatment\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 42 -->\n\n↑ FENO\n\nIncrease\n*   Asthma ± atopy\n*   Allergic rhinitis\n*   COPD ± exacerbation\n*   Bronchiectasis\n*   Primary lung cancer\n*   Lung transplant (acute rejection)\n*   Rhinoviral infection/urti\n\n↓ nasal NO\nLOW FENO IN Primary ciliary dyskinesia:\n\nHypothesized reason for low nNO values in PCD patients include **increased nNO metabolism** **reduced production of NO by airway epithelial cells**, and abnormalities in the paranasal sinuses leading to **obstruction of NO** or reduced production at that site.\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 43 -->\n\nASSESSMENT OF\nSMALL AIRWAY\nDISEASE / SAD\n\nSmall is\npowerful\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n14\n\n---\n\n<!-- Page 44 (Error: No content extracted) -->\n\n<!-- Page 45 -->",
    "wordCount": 1370,
    "index": 2,
    "subTopicId": "1766794361794-d9nf9h13q"
  },
  {
    "id": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1--chunk-3",
    "bookId": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1-",
    "sectionTitle": "SPECIFIC CAUSES OF SMALL AIRWAYS DISEASES [Bronchiolar involvement]",
    "content": "# SPECIFIC CAUSES OF SMALL AIRWAYS DISEASES [Bronchiolar involvement]\n\n*   ✓ Infection especially in children → post viral bronchiolitis\n*   ✓ CTDs\n*   ✓ Transplant → B.O. obliterans → HP\n*   Environmental / occupational\n*   Drug induced\n*   Bronchiolar involvement in diseases also involving large airways Chronic obstructive pulmonary disease Bronchiectasis, including cystic fibrosis Asthma\n*   ✓ Diffuse panbronchiolitis\n\nEur Respir Rev 2013; 22: 126, 131-147\nDOI: 10.1183/09059180.00001313\nCopyright © ERS 2013\n\nREVIEW\n✓ Small airways diseases, excluding asthma and COPD: an overview\n\nDR. BHARATH KATHI MD DNB FIP PACI EDARM 16\n\n---\n\n<!-- Page 46 -->\n\n- Small airways obstruction may lead to\n- A reduction in airflow\n- Increased airways resistance\n- Gas trapping\n- Inhomogeneity of ventilation\n- Early diagnosis and treatment is needed to **prevent disease progression**\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM 17\n\n---\n\n<!-- Page 47 -->\n\n\n\n# DIAGNOSTIC METHODS for SAD\n\n*   **Pulmonary Function Test**\n    *   Spirometry ✓\n    *   Oscillometry ✓\n    *   Exhaled NO ✓\n    *   Plethysmography \\*\n    *   Dynamic compliance \\*\n    *   Inert gas washout \\*\n\n*   **IMAGING**\n    *   High resolution CT\n    *   Hyperpolarised helium ✓\n    *   MRI ✓ (can show ventilation pattern)\n    *   2D gamma scintigraphy ✓\n    *   SPECT ✓ (single photon emission CT)\n    *   PET ✓\n\n*   **BIOPSY**\n\nDr. Bharath Kathi MD DNB FIP FACI EDARM\n18\n\n---\n\n<!-- Page 48 -->\n\n\n\n# SPIROMETRY\n\n*   In health, the main site of airways resistance is the 4th-8th airway generation\n*   FEV1 largely reflects large airways obstruction $\\approx$ MEFR\n*   Forced Expiratory Flow between 25 and 75% of the FVC (FEF25-75)- latter part of the vital capacity is affected by increased resistance in small airways as lung volume decreases.\n*   **DISADVANTAGES**\n    *   Poor reproducibility as it is dependent on the FVC\n    *   There is poor correlation with other markers of small airways disease such as gas trapping and histological evidence of small airways inflammation\n\nDr. Bharath Kathi MD DNB. FIP FACIEDARM\n\n---\n\n<!-- Page 49 -->\n\n\n\n# FEV3 / FEV6 Ratio\n\n*   The ratio of forced expiratory volume in $\\text{\\textcircled{3}}$ and $\\text{\\textcircled{6}}$ seconds (FEV3/FEV6) has also emerged as an earlier and $\\underline{\\text{more sensitive marker of small airways}}$ disease compared with other spirometric measures\n*   Pts with $\\underline{\\text{low FEV3/FEV6}}$ found to be associated with $\\underline{\\text{impaired computed}}$ tomography ($\\underline{\\text{CT}}$) $\\underline{\\text{scanning}}$ measures of $\\underline{\\text{small airways disease}}$ in patients with $\\underline{\\text{normal FEV1/FVC}}$.\n\nDr. Bharath Kathi MD DNB FIP FACI EDARM\n20\n\n---\n\n<!-- Page 50 -->\n\n2. IOS\n\n*   Applying oscillating pressure variations of varying frequencies to the lung during normal tidal breathing, with the resulting pressure and flow changes measured at the mouth.\n*   Higher frequency signals reflect the contribution of larger airways, whereas low frequencies reflect the whole lung; as such, the contribution of the small airways can be found by comparing the two.\n\nSmall airways obstruction\nLarge airways obstruction\nNormal resistance\nResistance\nFrequency\n\nDr. Bharath Kathi MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 51 -->\n\n3. FENO\n\n*   Pt instructed to exhale at multiple flows (50, 100, 200, 260 ml/s) aided by visual feedback starting from a flow rate of 50 ml/s increasing to 260 ml/s, always in the same order\n*   Under low flow conditions-reflects central airways\n*   At higher flows -alveolar NO? Marker of distal airway inflammation\n\nIn both asthma and COPD, there is evidence that NO concentrations are elevated in the alveoli, suggesting that this may be a marker of small airways dysfunction.\n\nDr Bharath Kanthi\n\n---\n\n<!-- Page 52 -->\n\n\n\n# 4. BODY PLETHYSMOGTAPHY (BP)\n_Handwritten note: RV, TLC, RV/TLC_\n\n*   TLC : An increase to more than (120% of predicted) is considered as '**hyperinflation**'.\n*   It is usually **asthma or COPD** that leads to hyperinflation.\n*   ✓Because of early closure of airways during tidal exhalation, **air starts getting trapped inside the lungs of asthma and COPD patients**. _Handwritten note: { Air trapping_\n*   ✓This leads to greater increase in **residual volume (RV) than TLC**. (RV and TLC are underlined)\n*   ✓Consequently, **asthma and COPD patients have increased RV/TLC ratio which is often taken as a hallmark of obstructive airway disease**. _Handwritten note: { ↑RV / ↑TLC Δ:OAD_\n*   ⭐(Airways resistance) which provides a measure of airway obstruction may also be assessed by **body plethysmography by measuring the pressure required to drive airflow during tidal ventilation**.\n\nDr. Bharath Kathi MD DNB FIP FACI EDARM\n23\n\n---\n\n<!-- Page 53 -->\n\n\n\n# DYNAMIC COMPLIANCE\nasked on (10 marks) (OPD)\n\n$C = \\frac{dv}{dp} = \\text{change in volume per unit change in pressure}$\n*   Static means we are not taking airflow into consideration\n*   Dynamic means we are taking Air flow (movement)\n\n$\\checkmark$ Dynamic compliance, defined as the change in lung volume during airflow produced by a given change in transpulmonary pressure, is normally independent of breathing frequency.\n\n$\\circledast$ In normal persons, dynamic compliance closely approximates inspiratory static lung compliance (80%) and remains essentially unchanged even when breathing frequency is increased up to 60 breaths per minute.\n\n$\\checkmark$ This indicates that lung units that are parallel with each other normally fill and empty uniformly and synchronously, even when airflow is high and the change in lung volume is rapid.\n\n*   The rate of filling and emptying of a lung unit depends on its time constant—that is, the product of its resistance and compliance.\n\n$Tc = \\text{Resis} \\times \\text{Comp}$\n\nTRC\n\n---\n\n<!-- Page 54 -->\n\n\n\n# Dynamic compliance\n\n*   Lung units with high resistance take longer to fill and empty more slowly compared to units with low resistance. [Handwritten: SAD, Filled slow, Emptied late]\n*   Patchy narrowing of small peripheral airways produces regional differences in time constants.\n*   At low breathing frequencies, when the rate of airflow is low, ventilation is fairly evenly distributed.\n*   As the breathing frequency increases: ventilation tends to be distributed to areas that offer the least resistance to airflow. So lung units fed by narrowed airways receive proportionally less ventilation than do areas of the lung where the airways remain open.\n*   This frequency dependence of compliance was first noted in a patient with emphysema.\n\nDr. Bharath Kathi MD DNB FIP FACIEDARM\n25\n\n---\n\n<!-- Page 55 -->\n\n\n\n# MEASUREMENT\n\n*   During the test, the patient, with an esophageal balloon in place, first inspires maximally to TLC and then expires to the resting endexpiratory position (FRC); the patient then breathes at a normal tidal volume and respiratory rate (15 breaths per minute).\n    *   *Annotation:* N $\\text{C}_{\\text{dyn}} \\to 0.8 / \\text{C}_{\\text{st}}$\n*   Changes in tidal volume and transpulmonary pressure are displayed on oscilloscope and represented graphically.\n    *   *Annotation:* (Emphysema) $\\downarrow < 0.8$\n*   Then procedure is repeated with breathing frequencies of 30 and 60 breaths per minute. (15 - 30 - 60)\n*   In normal subjects, $\\text{C}_{\\text{dyn}}\\text{L}$ (dynamic compliance) remains nearly similar to $\\text{C}_{\\text{stat}}$ (80%), even at frequencies greater than 60 breaths per minute.\n*   However, in the presence of obstructive disease of the small airways $\\text{C}_{\\text{dyn}} / \\text{C}_{\\text{st}}\\text{L}$ falls progressively to values below 0.8 as breathing frequency increases.\n\n---\nDr. Bharath Kathi MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 56 -->\n\n*Values for dynamic compliance ($C_{dyn,L}$) at the various frequencies are expressed as a ratio of the dynamic compliance to the static inspiratory compliance ($C_{st,L}$) or as a percentage of $C_{st,L}$.*\n*Measurements of frequency dependence of dynamic compliance are time-consuming and technically difficult.*\n*May be useful in the diagnosis of obstruction in small peripheral airways when results of other conventional tests of lung mechanics are still within normal limits but rarely performed in pulmonary function laboratories.*\n\n**Graph Description:**\nThe graph shows $\\frac{C_{dyn,L}}{C_{st,L}} \\times 100 (\\%)$ on the y-axis against Respiratory frequency (breaths per minute) on the x-axis.\n*   **Normal:** The green line shows that for normal individuals, the ratio remains high (around 95-100%) across varying respiratory frequencies.\n*   **Small airways disease:** The blue/red line shows that for individuals with small airways disease, the ratio starts high but drops significantly as respiratory frequency increases, indicating frequency dependence of dynamic compliance.\n\nDr. Bharath Kathi MD DNB FIP FACI EDARM\n27\n\n---\n\n<!-- Page 57 -->\n\n\n\n# Single breath nitrogen washout test /\n\n\n## CLOSING VOLUME\n\n*   Poor asthma control was correlated with increases in closing volume\n*   Other techniques : Helium-Oxygen Flow-Volume Curves\n\n(OPD) *See CV/Compliance/Airway Resistance\n\n**Graph Labels:**\nN₂ Concentration (%)\nVolume (L)\nTLC\nRV\nCC\nCV\nI\nII\nIII\nIV\n\nDr. Bharath Karthi MD DNB FIP FACEDARM\n28\n\n---\n\n<!-- Page 58 -->\n\nIMAGING\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n29\n\n---\n\n<!-- Page 59 -->\n\n\n\n# 1. HRCT CHEST\n\nHigh-resolution computed tomography (HRCT) is a noninvasive imaging technique that can quantify certain features of small airways disease, such as **air trapping** and **ventilation heterogeneity** (e.g. during expiration, as observed in the accompanying image).\n\n*   Unable to visualise **small airways directly**\n*   Specialist **software may be required**\n*   **No standardised measurements** (annotated with a cross-checkmark)\n*   **Radiation dose** (annotated with a cross-checkmark and handwritten text: \"for more resolution\")\n\n---\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n30\n\n---\n\n<!-- Page 60 -->",
    "wordCount": 1491,
    "index": 3,
    "subTopicId": "1766794361794-d9nf9h13q"
  },
  {
    "id": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1--chunk-4",
    "bookId": "40-pft-series--impulse-oslmtry-feno-tests-for-sad-ocr-complete--1-",
    "sectionTitle": "2. Hyperpolarized helium-3 MRI",
    "content": "## 2. Hyperpolarized helium-3 MRI\n\n*   Subjects inhale a bolus of hyperpolarized helium3, enabling visualization of ventilation distribution within the lung.\n    *   *(Handwritten: Research \\**\n*   3He MRI provides a visually detailed image of the distribution of ventilation within the lung,\n*   Airway narrowing to the point of reduced ventilation or airway closure could both affect gas mixing and manifest as ventilation heterogeneity.\n*   However, it is not clear if the distribution of ventilation observed on 3 He MRI is sensitive to airway narrowing, airway closure, or a combination of the two.\n    *   *(Handwritten: [cannot say whether that airway Narrowing is dlt mucus plug / whether is dlt any SAD/obstructive or Mixed type])*\n\n---\n\n<!-- Page 61 -->\n\nE\n\ndifferent levels of ventilation (C1 = ventilation defect, C2–C5 = hypoventilation to hyperventilation\n\nC1 C2 C3 C4 C5\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM 32\n\n---\n\n<!-- Page 62 -->\n\n\n\n### 3. NUCLEAR MEDICINE\n\nScintigraphy uses radioactive tracers to obtain images of organs and/or record their functioning. It is a powerful tool that has been widely used to visualize and characterize intrapulmonary drug delivery in airways diseases such as asthma and COPD. It allows the measurement of overall lung deposition, and, to some extent, regional deposition (such as the lung periphery).\n\nThe accompanying scintigraphic images from a patient with asthma show aerosol deposition of radioactively labeled albuterol particles in the (a) posterior thorax and (b) anterior thorax, which were recorded sequentially, with the patient repositioned between views. Red areas indicate regions of highest radioactivity and black of least radioactivity.\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 63 -->\n\n\n\n# SPECT : Single Photon Emission Computed Tomography\n\n\n## ? 3D VENTILATION SCAN\n\n\n\n### Single-photon emission computed tomography\n\nSingle-photon emission computed tomography (SPECT) is a 3-dimensional nuclear imaging technique involving use of radioactive tracers to highlight certain features of organs/tissues, such as the patchy distribution of small airways disease. Single-photon emission computed tomography images are sometimes combined with traditional computed tomography images to correlate functional and structural features.\n\nThe accompanying Technegas ventilation SPECT/computed tomography (CT) fusion image shows the axial dimension of a 68-year-old man with moderately severe COPD. It highlights well-ventilated areas of the lung (bright yellow), less-ventilated areas (red) and nonventilated areas (black). Green indicates emphysema.\nIt is apparent that poorly ventilated areas tend to correspond with areas of emphysema.\n\n---\n\n<!-- Page 64 -->\n\nPositron emission tomography\nA B\nPositron emission tomography (PET), which may also be combined _with CT_, is another three-dimensional\nnuclear imaging technique that allows visualization of the regional deposition of _radiolabeled tracers_. The major\ndifference compared with SPECT is a higher radiation exposure, leading to higher-resolution images.\nThe accompanying PET images show (a) 3-dimensional and (b) coronal views illustrating the distribution of\nan inflammatory biomarker, ¹⁸_fluorodeoxyglucose_, predominantly in _the upper lungs of a patient with COPD_.\nThe range of colors indicate uptake of biomarker, with maximum uptake represented by white and minimum uptake\nby black.\n\n---\n\n<!-- Page 65 -->\n\nTHE NAME IS SAD &\nIT CAN BE BAD\nIDENTIFY EARLY &\nRx APPROPRIATELY\n\nTHANK YOU\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n36\n\n---",
    "wordCount": 526,
    "index": 4,
    "subTopicId": "1766794361794-d9nf9h13q"
  }
]